Quinolinic acid: An endogenous neurotoxin with multiple targets

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Lugo Huitrón, Rafael ^a   Ugalde Muñiz, Perla ^a   Pineda, Benjamin ^a   Pedraza Chaverrí, José ^b   Ríos, Camilo ^a   Pérez De La Cruz, Verónica ^a  

^a NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^b Universidad Nacional Autonoma de Mexico Facultad de Quimica   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBRO SPINAL FLUIDS; KYNURENINE PATHWAYS; MULTIPLE TARGETS; N-METHYL-D-ASPARTATE; NANOMOLAR CONCENTRATION; NEUROLOGICAL DISEASE; RELEVANT TARGET; UPTAKE SYSTEMS;

BRAIN; CELL DEATH; CEREBROSPINAL FLUID; TOXICITY;

PYRIDINE;

ACICLOVIR; ARGININE; CARNITINE; DEFEROXAMINE; DIZOCILPINE; EBSELEN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HUNTINGTIN; LICOFELONE; MELATONIN; MEMANTINE; MONTELUKAST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE Y; NIMESULIDE; PIOGLITAZONE; POLYAMINE; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; ROFECOXIB; SELENIUM; SOMATOSTATIN; SPERMIDINE; SPERMINE; SULINDAC; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOREDOXIN REDUCTASE; TOLMETIN; NEUROTOXIN;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; BIOSYNTHESIS; BLOOD BRAIN BARRIER; BRAIN METABOLISM; CELL DEATH; CHEMICAL STRUCTURE; DEGENERATIVE DISEASE; DEPRESSION; ENERGY TRANSFER; ENZYME DEGRADATION; EXCITOTOXICITY; EXPLORATORY BEHAVIOR; FENTON REACTION; GLUCONEOGENESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; METABOLIC INHIBITION; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; REFERENCE MEMORY; REVIEW; SUICIDE; ANIMAL; CHEMISTRY; DRUG EFFECTS; ENERGY METABOLISM; PATHOLOGY; TOXICITY; DRUG EFFECT;

ANIMALS; ENERGY METABOLISM; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES; NEUROTOXINS; OXIDATIVE STRESS; QUINOLINIC ACID;

EID: 84884856782     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/104024     Document Type: Review

References (143)

1. Musajo L., Benassi C. A., Aspects of disorders of the Kynurenine pathway of Tryptophan metabolism in man. Advances in Clinical Chemistry 1964 7 63 135 2-s2.0-0001868532 10.1016/S0065-2423(08)60373-X
2. Wolf H., The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scandinavian Journal of Clinical and Laboratory Investigation 1974 136 1 186 2-s2.0-0016007501
3. Anderson R. M., Bitterman K. J., Wood J. G., Medvedik O., Cohen H., Lin S. S., Manchester J. K., Gordon J. I., Sinclair D. A., Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. The Journal of Biological Chemistry 2002 277 21 18881 18890 2-s2.0-0037166274 10.1074/jbc.M111773200 (Pubitemid 34952448)
4. Massudi H., Grant R., Guillemin G. J., Braidy N., NAD+ metabolism and oxidative stress: the golden nucleotide on a crown of thorns. Redox Report 2012 17 1 28 46 2-s2.0-84857286276 10.1179/1351000212Y.0000000001
5. Bender D. A., McCreanor G. M., The preferred route of kynurenine metabolism in the rat. Biochimica et Biophysica Acta 1982 717 1 56 60 2-s2.0-0020485118
6. Foster A. C., White R. J., Schwarcz R., Synthesis of quinolinic acid by 3-hydroxyanthranilic acid oxygenase in rat brain tissue in vitro. Journal of Neurochemistry 1986 47 1 23 30 2-s2.0-0022471686 (Pubitemid 16069167)
7. Braidy N., Grant R., Brew B. J., Adams S., Jayasena T., Guillemin G. J., Effects of kynurenine pathway metabolites on intracellular NAD+ synthesis and cell death in human primary astrocytes and neurons. International Journal of Tryptophan Research 2009 2 1 61 69 2-s2.0-67651228062
8. Stone T. W., Neuropharmacology of quinolinic and kynurenic acids. Pharmacological Reviews 1993 45 3 309 379 2-s2.0-0027486072 (Pubitemid 23292874)
9. Roberts R. C., McCarthy K. E., Du F., Ottersen P., Okuno E., Schwarcz R., 3-Hydroxyanthranilic acid oxygenase-containing astrocytic processes surround glutamate-containing axon terminals in the rat striatum. The Journal of Neuroscience 1995 15 2 1150 1161 2-s2.0-0028931873
10. Foster A. C., Whetsell W. O. Jr., Bird E. D., Schwarcz R., Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum. Brain Research 1985 336 2 207 214 2-s2.0-0021832252 10.1016/0006-8993(85)90647-X (Pubitemid 15008370)
11. Foster A. C., Zinkand W. C., Schwarcz R., Quinolinic acid phosphoribosyltransferase in rat brain. Journal of Neurochemistry 1985 44 2 446 454 2-s2.0-0021970942 (Pubitemid 15196077)
12. McDaniel H. G., Reddy W. J., Boshell B. R., The mechanism of inhibition of phosphoenolpyruvate carboxylase by quinolinic acid. Biochimica et Biophysica Acta 1972 276 2 543 550 2-s2.0-0015527353
13. Heyes M. P., Achim C. L., Wiley C. A., Major E. O., Saito K., Markey S. P., Human microglia convert L-tryptophan into the neurotoxin quinolinic acid. The Biochemical Journal 1996 320 2 595 597 2-s2.0-0029960647 (Pubitemid 26417785)
14. Guillemin G. J., Smith D. G., Smythe G. A., Armati P. J., Brew B. J., Expression of the kynurenine pathway enzymes in human microglia and macrophages. Advances in Experimental Medicine and Biology 2003 527 105 112 2-s2.0-1042302739 (Pubitemid 38197634)
15. Guillemin G. J., Smythe G., Takikawa O., Brew B. J., Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. GLIA 2005 49 1 15 23 2-s2.0-11144314849 10.1002/glia.20090 (Pubitemid 40023649)
16. Moroni F., Lombardi G., Carla V., Moneti G., The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain. Brain Research 1984 295 2 352 355 2-s2.0-0021338289 10.1016/0006-8993(84)90984-3 (Pubitemid 14161043)
17. Moroni F., Lombardi G., Moneti G., Aldinio C., The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process. Neuroscience Letters 1984 47 1 51 55 2-s2.0-0021262777 10.1016/0304-3940(84)90385-9 (Pubitemid 14111333)
18. Chen Y., Guillemin G. J., Kynurenine pathway metabolites in humans: disease and healthy states. International Journal of Tryptophan Research 2009 2 1 1 19 2-s2.0-73249121300
19. Foster A. C., Miller L. P., Oldendorf W. H., Schwarcz R., Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat. Experimental Neurology 1984 84 2 428 440 2-s2.0-0021354501 (Pubitemid 14141457)
20. Kohler C., Eriksson L. G., Flood P. R., Hardie J. A., Okuno E., Schwarcz R., Quinolinic acid metabolism in the rat brain. Immunohistochemical identification of 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyltransferase in the hippocampal region. The Journal of Neuroscience 1988 8 3 975 987 2-s2.0-0023860251 (Pubitemid 18085164)
21. Foster A. C., Okuno E., Brougher D. S., Schwarcz R., A radioenzymatic assay for quinolinic acid. Analytical Biochemistry 1986 158 1 98 103 2-s2.0-0022970173 (Pubitemid 17184464)
22. Müller A. C., Dairam A., Limson J. L., Daya S., Mechanisms by which acyclovir reduces the oxidative neurotoxicity and biosynthesis of quinolinic acid. Life Sciences 2007 80 10 918 925 2-s2.0-33846626403 10.1016/j.lfs.2006.11. 031 (Pubitemid 46186426)
23. Stachowski E. K., Schwarcz R., Regulation of quinolinic acid neosynthesis in mouse, rat and human brain by iron and iron chelators in vitro. Journal of Neural Transmission 2012 119 2 123 131 2-s2.0-84857631724 10.1007/s00702-011- 0694-6
24. Guillemin G. J., Quinolinic acid: neurotoxicity. The FEBS Journal 2012 279 8 1355 2-s2.0-84859563150 10.1111/j.1742-4658.2012.08493.x
25. Rahman A., Ting K., Cullen K. M., Braidy N., Brew B. J., Guillemin G. J., The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS ONE 2009 4 7 2-s2.0-67651243648 10.1371/journal.pone.0006344 e6344
26. Guillemin G. J., Brew B. J., Noonan C. E., Takikawa O., Cullen K. M., Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathology and Applied Neurobiology 2005 31 4 395 404 2-s2.0-23044462498 10.1111/j.1365-2990.2005.00655.x (Pubitemid 41059860)
27. Stone T. W., Connick J. H., Quinolinic acid and other kynurenines in the central nervous system. Neuroscience 1985 15 3 597 617 2-s2.0-0022416845 10.1016/0306-4522(85)90063-6 (Pubitemid 15236335)
28. Lapin I. P., Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. Journal of Neural Transmission 1978 42 1 37 43 2-s2.0-0017887867 (Pubitemid 8271036)
29. Stone T. W., Perkins M. N., Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. European Journal of Pharmacology 1981 72 4 411 412 2-s2.0-0019440926 (Pubitemid 11081065)
30. Schwarcz R., Whetsell W. O. Jr., Mangano R. M., Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 1983 219 4582 316 318 2-s2.0-0020702374 (Pubitemid 13222319)
31. Prado de Carvalho L., Bochet P., Rossier J., The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochemistry International 1996 28 4 445 452 2-s2.0-0342468278 10.1016/0197-0186(95)00091-7 (Pubitemid 26120215)
32. Schwarcz R., Kohler C., Differential vulnerability of central neurons of the rat to quinolinic acid. Neuroscience Letters 1983 38 1 85 90 2-s2.0-0020591879 10.1016/0304-3940(83)90115-5 (Pubitemid 13029108)
33. Nakanishi S., Molecular diversity of glutamate receptors and implications for brain function. Science 1992 258 5082 597 603 2-s2.0-0026437728
34. Foster A. C., Collins J. F., Schwarcz R., On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 1983 22 12 1331 1342 2-s2.0-0021042967 (Pubitemid 14222225)
35. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J., Martin J. B., Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986 321 6066 168 171 2-s2.0-0022446150 (Pubitemid 16022019)
36. Tavares R. G., Tasca C. I., Santos C. E. S., Wajner M., Souza D. O., Dutra-Filho C. S., Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain. NeuroReport 2000 11 2 249 253 2-s2.0-0033959453 (Pubitemid 30074627)
37. Tavares R. G., Tasca C. I., Santos C. E. S., Alves L. B., Porciúncula L. O., Emanuelli T., Souza D. O., Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochemistry International 2002 40 7 621 627 2-s2.0-0036128148 10.1016/S0197-0186(01)00133-4 (Pubitemid 34246240)
38. Baverel G., Martin G., Michoudet C., Glutamine synthesis from aspartate in guinea-pig renal cortex. The Biochemical Journal 1990 268 2 437 442 2-s2.0-0025295943 (Pubitemid 20193985)
39. Ting K. K., Brew B. J., Guillemin G. J., Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer's disease. Journal of Neuroinflammation 2009 6, article 36 2-s2.0-73249145672 10.1186/1742-2094-6-36
40. Guillemin G. J., Cullen K. M., Lim C. K., Smythe G. A., Garner B., Kapoor V., Takikawa O., Brew B. J., Characterization of the kynurenine pathway in human neurons. The Journal of Neuroscience 2007 27 47 12884 12892 2-s2.0-36448939072 10.1523/JNEUROSCI.4101-07.2007 (Pubitemid 350161746)
41. Sei Y., Fossom L., Goping G., Skolnick P., Basile A. S., Quinolinic acid protects rat cerebellar granule cells from glutamate- induced apoptosis. Neuroscience Letters 1998 241 2-3 180 184 2-s2.0-0032579506 10.1016/S0304- 3940(97)00980-4 (Pubitemid 28114191)
42. Whetsell W. O. Jr., Schwarcz R., Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system. Neuroscience Letters 1989 97 3 271 275 2-s2.0-0024499063 (Pubitemid 19047470)
43. Kerr S. J., Armati P. J., Guillemin G. J., Brew B. J., Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex. AIDS 1998 12 4 355 363 2-s2.0-0032485464 (Pubitemid 28077531)
44. Pierozan P., Zamoner A., Krombauer Soska Â., Bristot Silvestrin R., Oliveira Loureiro S., Heimfarth L., Mello e Souza T., Wajner M., Pessoa-Pureur R., Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats. Experimental Neurology 2010 224 1 188 196 2-s2.0-77953700414 10.1016/j.expneurol.2010.03.009
45. Pierozan P., Zamoner A., Soska Â. K., De Lima B. O., Reis K. P., Zamboni F., Wajner M., Pessoa-Pureur R., Signaling mechanisms downstream of quinolinic acid targeting the cytoskeleton of rat striatal neurons and astrocytes. Experimental Neurology 2012 233 1 391 399 2-s2.0-84856208813 10.1016/j.expneurol.2011.11.005
46. +-ATPase function. Neurochemical Research 2008 33 9 1749 1758 2-s2.0-48349109173 10.1007/s11064-008-9619-7
47. Naoi M., Ishiki R., Nomura Y., Hasegawa S., Nagatsu T., Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes. Neuroscience Letters 1987 74 2 232 236 2-s2.0-0023122720 (Pubitemid 17013850)
48. Bordelon Y. M., Chesselet M.-F., Nelson D., Welsh F., Erecińska M., Energetic dysfunction in quinolinic acid-lesioned rat striatum. Journal of Neurochemistry 1997 69 4 1629 1639 2-s2.0-0030886120 (Pubitemid 27406964)
49. Bordelon Y. M., Chesselet M.-F., Erecińska M., Silver I. A., Effects of intrastriatal injection of quinolinic acid on electrical activity and extracellular ion concentrations in rat striatum in vivo. Neuroscience 1998 83 2 459 469 2-s2.0-0031906009 10.1016/S0306-4522(97)00421-1 (Pubitemid 28062636)
50. Pérez-Severiano F., Escalante B., Ríos C., Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity. Neurochemical Research 1998 23 10 1297 1302 2-s2.0-0031763724 10.1023/A:1020700401678 (Pubitemid 28495700)
51. Cabrera J., Reiter R. J., Tan D.-X., Qi W., Sainz R. M., Mayo J. C., Garcia J. J., Kim S. J., El-Sokkary G., Melatonin reduces oxidative neurotoxicity due to quinolinic acid: in vitro and in vivo findings. Neuropharmacology 2000 39 3 507 514 2-s2.0-0033978674 10.1016/S0028-3908(99) 00128-8 (Pubitemid 30052939)
52. Ganzella M., Jardim F. M., Boeck C. R., Vendite D., Time course of oxidative events in the hippocampus following intracerebroventricular infusion of quinolinic acid in mice. Neuroscience Research 2006 55 4 397 402 2-s2.0-33744975232 10.1016/j.neures.2006.05.003 (Pubitemid 43866260)
53. Ribeiro C. A., Grando V., Dutra Filho C. S., Wannmacher C. M., Wajner M., Evidence that quinolinic acid severely impairs energy metabolism through activation of NMDA receptors in striatum from developing rats. Journal of Neurochemistry 2006 99 6 1531 1542 (Pubitemid 44924231)
54. Schuck P. F., Tonin A., da Costa Ferreira G., Rosa R. B., Latini A., Balestro F., Perry M. L. S., Wannmacher C. M. D., de Souza Wyse A. T., Wajner M., In vitro effect of quinolinic acid on energy metabolism in brain of young rats. Neuroscience Research 2007 57 2 277 288 2-s2.0-33846612733 10.1016/j.neures.2006.10.013 (Pubitemid 46177297)
55. Blanco-Ayala T., Serratos-Alvarez I., Orozco-Ibarra M., Effect of some kynurenines under succinate deshidrogenase activity and ATP production: in vitro experimental and computational tools. Neuroscience Meeting 2012 60.09 New Orleans, LA, USA Society for Neuroscience
56. Lapin I. P., Mirzaev S. M., Ryzov I. V., Oxenkrug G. F., Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. Journal of Pineal Research 1998 24 4 215 218 2-s2.0-0031966042 10.1111/j.1600-079X.1998.tb00535.x (Pubitemid 28206441)
57. Southgate G. S., Daya S., Potgieter B., Melatonin plays a protective role in quinolinic acid-induced neurotoxicity in the rat hippocampus. Journal of Chemical Neuroanatomy 1998 14 3-4 151 156 2-s2.0-0032104709 10.1016/S0891- 0618(98)00026-X (Pubitemid 28362417)
58. Antunes Wilhelm E., Ricardo Jesse C., Folharini Bortolatto C., Wayne Nogueira C., Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin. European Journal of Pharmacology 2013 701 1-3 65 72
59. Behan W. M. H., McDonald M., Darlington L. G., Stone T. W., Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. British Journal of Pharmacology 1999 128 8 1754 1760 2-s2.0-0033406026 (Pubitemid 30011889)
60. Nakao N., Brundin P., Effects of α -phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Neuroscience 1996 76 3 749 761 2-s2.0-0030580581 10.1016/S0306-4522(96)00223-0 (Pubitemid 27013415)
61. Bellé N. A. V., Dalmolin G. D., Fonini G., Rubin M. A., Rocha J. B. T., Polyamines reduces lipid peroxidation induced by different pro-oxidant agents. Brain Research 2004 1008 2 245 251 2-s2.0-2442450579 10.1016/j.brainres.2004.02.036 (Pubitemid 38624055)
62. Stipek S., Stastny F., Platenik J., Crkovska J., Zima T., The effect of quinolinate on rat brain lipid peroxidation is dependent on iron. Neurochemistry International 1997 30 2 233 237 2-s2.0-0031024185 10.1016/S0197-0186(96)00067-8 (Pubitemid 27029182)
63. Santamaría A., Galván-Arzate S., Lisý V., Ali S. F., Duhart H. M., Osorio-Rico L., Ríos C., Sut'astný F., Quinolinic acid induces oxidative stress in rat brain synaptosomes. NeuroReport 2001 12 4 871 874 2-s2.0-0035953168 (Pubitemid 32222733)
64. Santamaría A., Vázquez-Román B., Pérez-De La Cruz V., González-Cortés C., Trejo-Solís M. C., Galván-Arzate S., Jara-Prado A., Guevara-Fonseca J., Ali S. F., Selenium reduces the proapoptotic signaling associated to NF- B pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatum. Synapse 2005 58 4 258 266 2-s2.0-28044431816 10.1002/syn.20206 (Pubitemid 41690810)
65. Santamaría A., Salvatierra-Sánchez R., Vázquez- Román B., Santiago-López D., Villeda-Hernández J., Galván-Arzate S., Jiménez-Capdeville M. E., Ali S. F., Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. Journal of Neurochemistry 2003 86 2 479 488 2-s2.0-18244412070 10.1046/j.1471-4159.2003.01857.x (Pubitemid 36842447)
66. Maldonado P. D., Perez-De La Cruz V., Torres-Ramos M., Selenium-induced antioxidant protection recruits modulation of thioredoxin reductase during excitotoxic/pro-oxidant events in the rat striatum. Neurochemistry International 2012 61 2 195 206
67. Rossato J. I., Zeni G., Mello C. F., Rubin M. A., Rocha J. B. T., Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neuroscience Letters 2002 318 3 137 140 2-s2.0-0036468684 10.1016/S0304-3940(01)02504-6 (Pubitemid 34136028)
68. Swathy S. S., Indira M., The Ayurvedic drug, Ksheerabala, ameliorates quinolinic acid-induced oxidative stress in rat brain. International Journal of Ayurveda Research 2010 1 1 4 9
69. Kalonia H., Kumar P., Kumar A., Nehru B., Protective effect of montelukast against quinolinic acid/malonic acid induced neurotoxicity: possible behavioral, biochemical, mitochondrial and tumor necrosis factor- α level alterations in rats. Neuroscience 2010 171 1 284 299 2-s2.0-77957878655 10.1016/j.neuroscience.2010.08.039
70. Kalonia H., Kumar P., Kumar A., Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor- υ (PPAR υ) in Huntington's disease. Pharmacology Biochemistry and Behavior 2010 96 2 115 124 2-s2.0-77953706084 10.1016/j.pbb.2010.04.018
71. Kalonia H., Kumar P., Kumar A., Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011 35 2 607 615 2-s2.0-79952897660 10.1016/j.pnpbp.2011.01.003
72. Misztal M., Frankiewicz T., Parsons C. G., Danysz W., Learning deficits induced by chronic intraventricular infusion of quinolinic acid-protection by MK-801 and memantine. European Journal of Pharmacology 1996 296 1 1 8 2-s2.0-0030052030 10.1016/0014-2999(95)00682-6 (Pubitemid 26032230)
73. Kalonia H., Kumar P., Nehru B., Kumar A., Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats. Indian Journal of Experimental Biology 2009 47 11 880 892 2-s2.0-77449159593
74. Chen Y., Brew B. J., Guillemin G. J., Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis. Journal of Neurochemistry 2011 118 5 816 825 2-s2.0-80051796004 10.1111/j.1471-4159.2010.07159.x
75. Kalonia H., Kumar P., Kumar A., Nehru B., Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status. Neuroscience Bulletin 2009 25 6 343 352 2-s2.0-72349098221 10.1007/s12264-009-0513-3
76. Kalonia H., Kumar P., Kumar A., Nehru B., Protective effect of rofecoxib and nimesulide against intra-striatal quinolinic acid-induced behavioral, oxidative stress and mitochondrial dysfunctions in rats. NeuroToxicology 2010 31 2 195 203 2-s2.0-77649270021 10.1016/j.neuro.2009.12.008
77. Braidy N., Grant R., Adams S., Brew B. J., Guillemin G. J., Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotoxicity Research 2009 16 1 77 86 2-s2.0-70349754448 10.1007/s12640-009-9051-z
78. Connick J. H., Stone T. W., Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. British Journal of Pharmacology 1988 93 4 868 876 2-s2.0-0023876882 (Pubitemid 18093395)
79. Pérez-De La Cruz V., Konigsberg M., Pedraza-Chaverri J., Herrera-Mundo N., Díaz-Muñoz M., Morán J., Fortoul-Van Der Goes T., Rondán-Zárate A., Maldonado P. D., Ali S. F., Santamaría A., Cytoplasmic calcium mediates oxidative damage in an excitotoxic/energetic deficit synergic model in rats. The European Journal of Neuroscience 2008 27 5 1075 1085 2-s2.0-41149148819 10.1111/j.1460-9568.2008. 06088.x (Pubitemid 351432340)
80. Silva-Adaya D., Pérez-De La Cruz V., Herrera-Mundo M. N., Mendoza-Macedo K., Villeda-Hernández J., Binienda Z., Ali S. F., Santamaría A., Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine. Journal of Neurochemistry 2008 105 3 677 689 2-s2.0-42449104975 10.1111/j.1471-4159.2007.05174.x (Pubitemid 351562720)
81. Elinos-Calderón D., Robledo-Arratia Y., Pérez-De La Cruz V., Pedraza-Chaverrí J., Ali S. F., Santamaría A., Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities. Experimental Brain Research 2009 197 3 287 296 2-s2.0-70349587923 10.1007/s00221-009-1913-3
82. Dairam A., Chetty P., Daya S., Non-steroidal anti-inflammatory agents, tolmetin and sulindac, attenuate oxidative stress in rat brain homogenate and reduce quinolinic acid-induced neurodegeneration in rat hippocampal neurons. Metabolic Brain Disease 2006 21 2-3 221 233 2-s2.0-33847779004
83. Dairam A., Müller A. C., Daya S., Non-steroidal anti-inflammatory agents, tolmetin and sulindac attenuate quinolinic acid (QA)-induced oxidative stress in primary hippocampal neurons and reduce QA-induced spatial reference memory deficits in male Wistar rats. Life Sciences 2007 80 15 1431 1438 2-s2.0-33847771407 10.1016/j.lfs.2007.01.006 (Pubitemid 46389511)
84. Müller A. C., Maharaj H., Maharaj D. S., Daya S., Aciclovir protects against quinolinic-acid-induced oxidative neurotoxicity. Journal of Pharmacy and Pharmacology 2005 57 7 883 888 2-s2.0-21044440264 10.1211/0022357056442 (Pubitemid 40873938)
85. Santamaría A., Santamaría D., Díaz-Muñoz M., Espinoza-González V., Ríos C., Effects of N ω -nitro-L-arginine and L-arginine on quinolinic acid-induced lipid peroxidation. Toxicology Letters 1997 93 2-3 117 124 2-s2.0-0031441004 10.1016/S0378-4274(97) 00082-9 (Pubitemid 28055514)
86. Pérez-De La Cruz V., González-Cortés C., Galván-Arzate S., Medina-Campos O. N., Pérez-Severiano F., Ali S. F., Pedraza-Chaverrí J., Santamaría A., Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III). Neuroscience 2005 135 2 463 474 2-s2.0-24944529983 10.1016/j.neuroscience.2005.06.027 (Pubitemid 41317384)
87. Santiago-López D., Vázquez-Román B., Pérez-de la Cruz V., Barrera D., Rembao D., Salinas-Lara C., Pedraza-Chaverrí J., Galván-Arzate S., Ali S. F., Santamaría A., Peroxynitrite decomposition catalyst, iron metalloporphyrin, reduces quinolinate-induced neurotoxicity in rats. Synapse 2004 54 4 233 238 2-s2.0-8844273336 10.1002/syn.20084 (Pubitemid 39532064)
88. González-Cortés C., Salinas-Lara C., Gómez- López M. A., Tena-Suck M. L., Pérez-De La Cruz V., Rembao-Bojórquez D., Pedraza-Chaverrí J., Gómez-Ruiz C., Galván-Arzate S., Ali S. F., Santamaría A., Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate. Neurotoxicology and Teratology 2008 30 6 510 519 2-s2.0-53249095787 10.1016/j.ntt.2008.05.004
89. Sadeghnia H. R., Kamkar M., Assadpour E., Boroushaki M. T., Ghorbani A., Protective effect of Safranal, a constituent of crocus sativus, on quinolinic acid-induced oxidative damage in rat hippocampus. Iranian Journal of Basic Medical Sciences 2013 16 1 73 82
90. Braidy N., Grant R., Adams S., Guillemin G. J., Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. The FEBS Journal 2010 277 2 368 382 2-s2.0-74549166483 10.1111/j.1742-4658.2009.07487.x
91. Gulaj E., Pawlak K., Bien B., Pawlak D., Kynurenine and its metabolites in Alzheimer's disease patients. Advances in Medical Sciences 2010 55 2 204 211 2-s2.0-78650477632 10.2478/v10039-010-0023-6
92. Wu W., Nicolazzo J. A., Wen L., Chung R., Stankovic R., Bao S. S., Lim C. K., Brew B. J., Cullen K. M., Guillemin G. J., Expression of tryptophan 2, 3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PloS One 2013 8 4 e59749
93. Guillemin G. J., Smythe G. A., Veas L. A., Takikawa O., Brew B. J., A beta 1-42 induces production of quinolinic acid by human macrophages and microglia. Neuroreport 2003 14 18 2311 2315 2-s2.0-2342507918
94. Guidetti P., Luthi-Carter R. E., Augood S. J., Schwarcz R., Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease. Neurobiology of Disease 2004 17 3 455 461 2-s2.0-9644270316 10.1016/j.nbd.2004.07.006 (Pubitemid 39574879)
95. Guidetti P., Bates G. P., Graham R. K., Hayden M. R., Leavitt B. R., MacDonald M. E., Slow E. J., Wheeler V. C., Woodman B., Schwarcz R., Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice. Neurobiology of Disease 2006 23 1 190 197 2-s2.0-33745279104 10.1016/j.nbd.2006.02.011 (Pubitemid 43922462)
96. Heyes M. P., Saito K., Lackner A., Wiley C. A., Achim C. L., Markey S. P., Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB Journal 1998 12 10 881 896 2-s2.0-0031748985 (Pubitemid 28294678)
97. Heyes M. P., Brew B. J., Saito K., Quearry B. J., Price R. W., Lee K., Bhalla R. B., Der M., Markey S. P., Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. Journal of Neuroimmunology 1992 40 1 71 80 2-s2.0-0026655828 10.1016/0165-5728(92)90214-6
98. Guillemin G. J., Kerr S. J., Brew B. J., Involvement of quinolinic acid in aids dementia complex. Neurotoxicity Research 2005 7 1-2 103 123 2-s2.0-15844427653 10.1007/BF03033781
99. Erhardt S., Lim C. K., Linderholm K. R., Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 2013 38 5 743 752
100. Steiner J., Walter M., Gos T., Guillemin G. J., Bernstein H.-G., Sarnyai Z., Mawrin C., Brisch R., Bielau H., zu Schwabedissen L. M., Bogerts B., Myint A.-M., Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? Journal of Neuroinflammation 2011 8, article 94 2-s2.0-81155157520 10.1186/1742-2094-8-94
101. Zimmerman A. W., Jyonouchi H., Comi A. M., Connors S. L., Milstien S., Varsou A., Heyes M. P., Cerebrospinal fluid and serum markers of inflammation in autism. Pediatric Neurology 2005 33 3 195 201 2-s2.0-27644586632 10.1016/j.pediatrneurol.2005.03.014 (Pubitemid 41558217)
102. Chen Y., Stankovic R., Cullen K. M., Meininger V., Garner B., Coggan S., Grant R., Brew B. J., Guillemin G. J., The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotoxicity Research 2010 18 2 132 142 2-s2.0-77956706070 10.1007/s12640-009-9129-7
103. Flanagan E. M., Erickson J. B., Viveros O. H., Chang S. Y., Reinhard J. F. Jr., Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. Journal of Neurochemistry 1995 64 3 1192 1196 2-s2.0-0028821481
104. Füvesi J., Rajda C., Bencsik K., Toldi J., Vécsei L., The role of kynurenines in the pathomechanism of amyotrophic lateral sclerosis and multiple sclerosis: therapeutic implications. Journal of Neural Transmission 2012 119 2 225 234 2-s2.0-84857628333 10.1007/s00702-012-0765-3
105. Iwahashi H., Kawamori H., Fukushima K., Quinolinic acid, α -picolinic acid, fusaric acid, and 2,6-pyridinedicarboxylic acid enhance the Fenton reaction in phosphate buffer. Chemico-Biological Interactions 1999 118 3 201 215 2-s2.0-0032933765 10.1016/S0009-2797(99)00080-0 (Pubitemid 29179522)
106. Goda K., Kishimoto R., Shimizu S., Hamane Y., Ueda M., Quinolinic acid and active oxygens. Possible contribution of active Oxygens during cell death in the brain. Advances in Experimental Medicine and Biology 1996 398 247 254 2-s2.0-0030346563 (Pubitemid 126426237)
107. Perez-De La Cruz V., Elinos-Calderón D., Carrillo-Mora P., Silva-Adaya D., Konigsberg M., Morán J., Ali S. F., Chánez- Cárdenas M. E., Pérez-De La Cruz G., Santamaría A., Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition. Neurochemistry International 2010 56 6-7 834 842 2-s2.0-77952293112 10.1016/j.neuint.2010.03.008
108. Rodríguez-Martínez E., Camacho A., Maldonado P. D., Pedraza-Chaverrí J., Santamaría D., Galván-Arzate S., Santamaría A., Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Research 2000 858 2 436 439 2-s2.0-0343114486 10.1016/S0006-8993(99)02474-9 (Pubitemid 30120008)
109. Santamaría A., Jiménez-Capdeville M. E., Camacho A., Rodríguez-Martínez E., Flores A., Galván-Arzate S., In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. NeuroReport 2001 12 12 2693 2696 2-s2.0-0035964264 (Pubitemid 32803201)
110. Leipnitz G., Schumacher C., Scussiato K., Dalcin K. B., Wannmacher C. M. D., Wyse A. T. D., Dutra-Filho C. S., Wajner M., Latini A., Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats. International Journal of Developmental Neuroscience 2005 23 8 695 701 2-s2.0-27944460979 10.1016/j.ijdevneu.2005.08.004 (Pubitemid 41674508)
111. Noack H., Lindenau J., Rothe F., Asayama K., Wolf G., Differential expression of superoxide dismutase isoforms in neuronal and glial compartments in the course of excitotoxically mediated neurodegeneration: relation to oxidative and nitrergic stress. Glia 1998 23 4 285 297 (Pubitemid 28320595)
112. Tronel C., Rochefort G. Y., Arlicot N., Bodard S., Chalon S., Antier D., Oxidative stress is related to the deleterious effects of heme oxygenase-1 in an in vivo neuroinflammatory rat model. Oxidative Medicine and Cellular Longevity 2013 2013 10 264935 10.1155/2013/264935
113. Heyes M. P., Chen C. Y., Major E. O., Saito K., Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types. The Biochemical Journal 1997 326 2 351 356 2-s2.0-0030832112 (Pubitemid 27417209)
114. Espey M. G., Moffett J. R., Namboodiri M. A. A., Temporal and spatial changes of quinolinic acid immunoreactivity in the immune system of lipopolysaccharide stimulated mice. Journal of Leukocyte Biology 1995 57 2 199 206 2-s2.0-0028897091
115. Hanbury R., Ling Z. D., Wuu J., Kordower J. H., GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. Journal of Comparative Neurology 2003 461 3 307 316 2-s2.0-0038441556 10.1002/cne.10667 (Pubitemid 36648070)
116. Guillemin G. J., Croitoru-Lamoury J., Dormont D., Armati P. J., Brew B. J., Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. GLIA 2003 41 4 371 381 2-s2.0-0037337196 10.1002/glia.10175 (Pubitemid 36314150)
117. Beagles K. E., Morrison P. F., Heyes M. P., Quinolinic acid in vivo synthesis rates, extracellular concentrations, and intercompartmental distributions in normal and immune-activated brain as determined by multiple-isotope microdialysis. Journal of Neurochemistry 1998 70 1 281 291 2-s2.0-0031962269 (Pubitemid 28020854)
118. Block F., Schwarz M., Expression of GFAP in the striatum and its projection areas in response to striatal quinolinic acid lesion in rats. NeuroReport 1994 5 17 2237 2240 2-s2.0-0028027988 (Pubitemid 24374844)
119. Schiefer J., Töpper R., Schmidt W., Block F., Heinrich P. C., Noth J., Schwarz M., Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid. Journal of Neuroimmunology 1998 89 1-2 168 176 2-s2.0-0032516755 10.1016/S0165-5728(98)00133-7 (Pubitemid 28389589)
120. Kalonia H., Kumar A., Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats. Life Sciences 2011 88 17-18 784 791 2-s2.0-79954575048 10.1016/j.lfs.2011.02.020
121. Wilt S. G., Milward E., Zhou J. M., Nagasato K., Patton H., Rusten R., Griffin D. E., O'Connor M., Dubois-Dalcq M., In vitro evidence for a dual role of tumor necrosis factor- α in human immunodeficiency virus type 1 encephalopathy. Annals of Neurology 1995 37 3 381 394 2-s2.0-0028913223 10.1002/ana.410370315
122. Cammer W., Oligodendrocyte killing by quinolinic acid in vitro. Brain Research 2001 896 1-2 157 160 2-s2.0-0035970726 10.1016/S0006-8993(01)02017-0 (Pubitemid 32244159)
123. Pober J. S., Cotran R. S., Cytokines and endothelial cell biology. Physiological Reviews 1990 70 2 427 451 2-s2.0-0025304016 (Pubitemid 20140187)
124. Schulze-Osthoff K., Bakker A. C., Vanhaesebroeck B., Beyaert R., Jacob W. A., Fiers W., Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. The Journal of Biological Chemistry 1992 267 8 5317 5323 2-s2.0-0026713818
125. Hayashi M., Luo Y., Laning J., Strieter R. M., Dorf M. E., Production and function of monocyte chemoattractant protein-1 and other β -chemokines in murine glial cells. Journal of Neuroimmunology 1995 60 1-2 143 150 2-s2.0-0029166259 10.1016/0165-5728(95)00064-9
126. Heyes M. P., Quinolinic acid and inflammation. Annals of the New York Academy of Sciences 1993 679 211 216 2-s2.0-0027233683 (Pubitemid 23202410)
127. Sanberg P. R., Calderon S. F., Giordano M., Tew J. M., Norman A. B., The quinolinic acid model of Huntington's disease: locomotor abnormalities. Experimental Neurology 1989 105 1 45 53 2-s2.0-0024400046 (Pubitemid 19198876)
128. Pérez-De La Cruz V., Elinos-Calderón D., Robledo-Arratia Y., Medina-Campos O. N., Pedraza-Chaverrí J., Ali S. F., Santamaría A., Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease. Behavioural Brain Research 2009 199 2 210 217 2-s2.0-61349084796 10.1016/j.bbr.2008.11.037
129. Shear D. A., Dong J., Haik-Creguer K. L., Bazzett T. J., Albin R. L., Dunbar G. L., Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task. Experimental Neurology 1998 150 2 305 311 2-s2.0-0032051772 10.1006/exnr.1998.6767 (Pubitemid 28231962)
130. Vazey E. M., Chen K., Hughes S. M., Connor B., Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Experimental Neurology 2006 199 2 384 396 2-s2.0-33745235762 10.1016/j.expneurol.2006.01.034 (Pubitemid 43928967)
131. McGeer E. G., Singh E., Neurotoxic effects of endogenous materials: quinolinic acid, L-pyroglutamic acid, and thyroid releasing hormone (TRH). Experimental Neurology 1984 86 2 410 413 2-s2.0-0021713320 (Pubitemid 15218174)
132. Kells A. P., Henry R. A., Connor B., AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment. Gene Therapy 2008 15 13 966 977 2-s2.0-45749153812 10.1038/gt.2008.23 (Pubitemid 351865753)
133. Portera-Cailliau C., Price D. L., Martin L. J., Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. The Journal of Comparative Neurology 1997 378 1 88 104 (Pubitemid 27057533)
134. Ishidoh K., Kamemura N., Imagawa T., Oda M., Sakurai J., Katunuma N., Quinolinate phosphoribosyl transferase, a key enzyme in de novo NAD+ synthesis, suppresses spontaneous cell death by inhibiting overproduction of active-caspase-3. Biochimica et Biophysica Acta 2010 1803 5 527 533 2-s2.0-77951939034 10.1016/j.bbamcr.2010.02.007
135. Macaya A., Munell F., Gubits R. M., Burke R. E., Apoptosis in substantia nigra following developmental striatal excitotoxic injury. Proceedings of the National Academy of Sciences of the United States of America 1994 91 17 8117 8121 2-s2.0-0027956162 10.1073/pnas.91.17.8117 (Pubitemid 24253897)
136. Jeon B. S., Kholodilov N. G., Oo T. F., Kim S.-Y., Tomaselli K. J., Srinivasan A., Stefanis L., Burke R. E., Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra. Journal of Neurochemistry 1999 73 1 322 333 2-s2.0-0032995961 10.1046/j.1471-4159.1999.0730322.x (Pubitemid 29289141)
137. Guillemin G. J., Wang L., Brew B. J., Quinolinic acid selectively induces apoptosis of human astocytes: potential role in AIDS dementia complex. Journal of Neuroinflammation 2005 2, article 16 2-s2.0-27344457006 10.1186/1742-2094-2- 16 (Pubitemid 41522072)
138. Hughes P. E., Alexi T., Yoshida T., Schreiber S. S., Knusel B., Excitotoxic lesion of rat brain with quinolinic acid induces expression of p53 messenger RNA and protein and p53-inducible genes Bax and Gadd-45 in brain areas showing DNA fragmentation. Neuroscience 1996 74 4 1143 1160 2-s2.0-0030272509 10.1016/S0306-4522(96)00174-1 (Pubitemid 26313357)
139. Bordelon Y. M., Mackenzie L., Chesselet M. F., Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum. The Journal of Comparative Neurology 1999 412 1 38 50 (Pubitemid 29380323)
140. Wei H., Qin Z.-H., Senatorov V. V., Wei W., Wang Y., Qian Y., Chuang D.-M., Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease. Neuroscience 2001 106 3 603 612 2-s2.0-0035960005 10.1016/S0306-4522(01)00311-6 (Pubitemid 32925248)
141. Pérez-Navarro E., Gavaldà N., Gratacòs E., Alberch J., Brain-derived neurotrophic factor prevents changes in Bcl-2 family members and caspase-3 activation induced by excitotoxicity in the striatum. Journal of Neurochemistry 2005 92 3 678 691 2-s2.0-13244296828 10.1111/j.1471-4159.2004. 02904.x (Pubitemid 40189470)
142. Qin Z.-H., Wang Y., Chasea T. N., A caspase-3-like protease is involved in NF- B activation induced by stimulation of N-methyl-d-aspartate receptors in rat striatum. Molecular Brain Research 2000 80 2 111 122 2-s2.0-0034665797 10.1016/S0169-328X(00)00147-9
143. Wang Y., Dong X.-X., Cao Y., Liang Z.-Q., Han R., Wu J.-C., Gu Z.-L., Qin Z.-H., P53 induction contributes to excitotoxic neuronal death in rat striatum through apoptotic and autophagic mechanisms. The European The Journal of Neuroscience 2009 30 12 2258 2270 2-s2.0-72949091020 10.1111/j.1460-9568.2009. 07025.x